Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer.
Tsuruma T, Hata F, Torigoe T, Furuhata T, Idenoue S, Kurotaki T, Yamamoto M, Yagihashi A, Ohmura T, Yamaguchi K, Katsuramaki T, Yasoshima T, Sasaki K, Mizushima Y, Minamida H, Kimura H, Akiyama M, Hirohashi Y, Asanuma H, Tamura Y, Shimozawa K, Sato N, Hirata K.
Tsuruma T, et al. Among authors: katsuramaki t.
J Transl Med. 2004 Jun 13;2(1):19. doi: 10.1186/1479-5876-2-19.
J Transl Med. 2004.
PMID: 15193151
Free PMC article.